Related Experiment Videos
[Antiretroviral therapy in childhood]
1Charité-Klinikum, Berlin.
Insights
Early antiretroviral therapy is crucial for children with perinatal HIV infection due to higher viral loads and rapid disease progression. Guidelines for pediatric HIV treatment are essential given limited adult data applicability.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Immunology
Context:
- Perinatally acquired HIV infection in children presents unique challenges compared to adults.
- High initial viral loads and rapid progression to AIDS (up to 20% within the first year) necessitate early intervention.
- Limited data exists for antiretroviral therapy (ART) in pediatric populations, making treatment choices complex.
Purpose:
- To highlight the distinct natural history of childhood HIV infection.
- To emphasize the critical need for early antiretroviral therapy to prevent immune deterioration.
- To discuss current national and international guidelines for ART in perinatally HIV-infected children.
Summary:
- Childhood HIV infection acquired perinatally has a distinct course with higher viral loads and faster progression to AIDS.
- Early initiation of antiretroviral therapy is vital to halt disease progression before irreversible immune damage.
- Treatment selection is complicated by the lack of pediatric-specific data and the inapplicability of adult study results.
Impact:
- Informing clinical practice for managing pediatric HIV.
- Guiding the development of more effective, age-appropriate antiretroviral treatment strategies.
- Improving long-term outcomes and quality of life for children living with HIV.
Abstract:
The natural course of mostly perinatally acquired childhood HIV infection shows some special characteristics. Compared to adults the initial viral load is higher, persists for a longer period of time and without antiretroviral therapy up to 20% of infected children develop AIDS within the first year of life. It is therefore desirable to stop disease progression before an irreversible deterioration of the immune system has occurred by initiating early antiretroviral therapy. The choice of antiretroviral agents is difficult because data from adult studies cannot be directly applied to infants and data on antiretroviral therapy in pediatric patients are limited. The current national and international guidelines for antiretroviral therapy in perinatally acquired HIV infection are discussed.